Instructions and Guidelines
JOURNAL SCOPE
Journal of Addiction Medicine is a peer-reviewed journal designed to address the needs of the professional practicing in the ever-changing and challenging field of addiction medicine. Under the guidance of an esteemed Editorial Board, the Journal covers a wide range of topics relevant to clinical care and public health, including:
addiction and substance use in pregnancy
adolescent addiction and at-risk use
the drug-exposed neonate
pharmacology
all psychoactive substances relevant to addiction, including alcohol, nicotine, caffeine, marijuana, opioids, stimulants and other prescription and illicit substances
diagnosis
neuroimaging techniques
treatment of special populations
treatment, early intervention and prevention of alcohol and drug use disorders
methodological issues in addiction research
pain and addiction, prescription drug use disorder
co-occurring addiction, medical and psychiatric disorders
pathological gambling disorder, sexual and other behavioral addictions
pathophysiology of addiction
behavioral and pharmacological treatments
issues in graduate medical education
recovery
health services delivery
ethical, legal and liability issues in addiction medicine practice
drug testing
self- and mutual-help
Back to top of page
ETHICAL/LEGAL CONSIDERATIONS
Patient anonymity and informed consent
It is the author's responsibility to ensure that a patient's anonymity be carefully protected. Authors must verify that any investigation with human subjects reported in the manuscript was performed with informed consent or with a waiver approved by the appropriate ethics board, and following all the guidelines for experimental investigation with human subjects required by the institution(s) and localities with which all the authors are affiliated. If consent was not obtained, explain why. Authors must obtain written consent from people shown in figures and submit written consent with the manuscript. To further protect anonymity, consider masking eyes. Names should be removed from any figures or photographs. See also policy on case report consent.
Protection of Human Subjects and Animals in Research
For any manuscripts involving human subjects’ research, always include a statement in the methods section describing ethics (institutional review) board review and approval and consent. When reporting experiments on human subjects, author must confirm that the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration, as revised in 2004:
http://www.wma.net/en/30publications/10policies/b3/ If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors must confirm that institutional and national guides for the care and use of laboratory animals were followed.
Journal of Addiction Medicine consent policy for case reports
There is no universal consensus regarding consent for publication of case reports, except cases that are identifiable can only be published when consent has been obtained. Note that such consent is different from research participant consent, which applies to systematic investigation of a subject or subjects with intent to generalize the findings. Consent to publish the details of an individual’s case is obtained to respect the person’s right to privacy.
Institutional review and ethics boards make determinations about consent for research. However, even if consent is waived for research and even if a case report is deemed to not constitute research, consent is often required for other reasons (privacy). If a case report or case series is deemed to be research (systematic collection of data with an intent to generalize the findings) then report of approval and relevant consent should be stated as with all other research. When two cases are reported, institutional review or ethics board review is recommended; in general, such review is required when 3 or more cases are reported.
Consent from the subject (or parent/guardian) should be obtained for all case reports. Consent can be on an institutional document or one similar to the examples below (modified as appropriate), and should be stored for seven years and made available to the editors and publisher on request. State in the cover letter that written consent to publish a report of the case has been obtained by the subject and that it is available for review by the editors and publisher of the journal.
If the subject is deceased, consent should be provided by family or significant others (next-of-kin). If consent has not been obtained, the authors must describe the circumstances of how they attempted to obtain consent or why it was not possible.
If consent is not obtained, the editors, alone or in consultation with the publisher and/or peer reviewers, will consider the extent to which the case appears to be anonymous and the exhaustive and reasonable nature of attempts to obtain consent, and whether there is any reason to suspect that a patient might have objected to publication. The authors should carefully attempt to protect the patient’s identity. Then the journal will attempt to balance the risk of deductive disclosure with the benefit to public health and science. Authors should keep in mind however, that even without the inclusion of identifiers, real cases can often be identified by people in the community since cases worthy of reporting are often recognizable.
……
更多详情：
https://journals.lww.com/journaladdictionmedicine/Pages/Instructions-and-Guidelines.aspx
